Literature DB >> 25642815

Incremental Healthcare Service Utilization for Open-angle Glaucoma: A Population-Based Study.

Shiu-Dong Chung1, Jau-Der Ho, Herng-Ching Lin, Li-Ting Kao, Ming-Chieh Tsai.   

Abstract

PURPOSE: To investigate differences in the utilization of healthcare services between subjects with open-angle glaucoma (OAG) and comparison subjects without OAG using Taiwan's National Health Insurance population-based database. PATIENTS AND METHODS: The study comprised 2204 subjects with OAG and 2204 sex-matched and age-matched subjects without OAG. We individually followed each subject for a 1-year period to evaluate their healthcare resource utilization. Outcome variables of the healthcare resource utilization were as follows: numbers of outpatient visits and inpatient days and the mean costs of outpatient and inpatient treatment. In addition, we divided healthcare resource utilization into ophthalmologic and nonophthalmologic services.
RESULTS: As for the utilization of ophthalmologic services, OAG subjects had significantly more outpatient visits (7.4 vs. 1.3, P<0.001) and significantly higher outpatient costs (US$272 vs. US$39, P<0.001) than comparison subjects. For nonophthalmologic services, OAG subjects also had significantly more outpatient visits (29.4 vs. 21.8, P<0.001) and significantly higher outpatient costs (US$1263 vs. US$847, P<0.001) than comparison subjects. Furthermore, OAG subjects incurred significantly higher inpatient costs compared with comparison subjects (US$434 vs. US$234, P<0.001). For all healthcare services, OAG subjects had significantly more outpatient visits (36.8 vs. 23.1, P<0.001) and significantly higher outpatient (US$1535 vs. US$887, P<0.001) and total (US$2245 vs. US$1122, P<0.001) costs than comparison subjects. In other words, the total cost was about 2-fold greater for OAG subjects than comparison subjects.
CONCLUSIONS: We concluded that subjects with OAG had significantly higher utilization of all healthcare services than comparison subjects.

Entities:  

Mesh:

Year:  2015        PMID: 25642815     DOI: 10.1097/IJG.0000000000000222

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  2 in total

1.  Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study.

Authors:  Ying Ying Chen; Tsing-Hong Wang; Catherine Liu; Kwou-Yeung Wu; Shin-Lin Chiu; Susan Simonyi; Da-Wen Lu
Journal:  BMC Ophthalmol       Date:  2016-09-15       Impact factor: 2.209

2.  Geographical variation in glaucoma prescribing trends in England 2008-2012: an observational ecological study.

Authors:  Jacob S Heng; Richard Wormald; Peng Tee Khaw
Journal:  BMJ Open       Date:  2016-05-17       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.